Jason Snibbe
Orthopaedic Surgery · Los Angeles, CANPI 1932271970
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $228,130 of the $276,352 with a category attached, or 82.6%. Stryker accounts for 99.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $85,574 and has fallen 85.9% since, to $12,034 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $850.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$275K
- Smith+Nephew$304
- Catalyst Orthoscience$155
- Saxum Surgical, Inc.$140
- Bioventus LLC$112
- Pacira Pharmaceuticals Incorporated$67
- plus $310 from 10 others
Across 2 payments — averaging $16,675 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$33K
- Radlink, Inc$0
What the payments were for
- Consulting fees$228,13083%
- Travel & lodging$38,29014%
- Food & beverage$9,9134%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 302 | $275,264 |
| Smith+Nephew | 4 | $304 |
| Catalyst Orthoscience | 1 | $155 |
| Saxum Surgical, Inc. | 1 | $140 |
| Bioventus LLC | 3 | $112 |
| Pacira Pharmaceuticals Incorporated | 1 | $67 |
| Circinus Medical Technology LLC | 1 | $58 |
| Dynasplint Systems Inc. | 2 | $48 |
| Heron Therapeutics, Inc. | 2 | $44 |
| DJO, LLC | 2 | $37 |
| Biotissue Holdings Inc. | 1 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Johnson & Johnson | 1 | $19 |
| Overture Orthopaedics | 1 | $19 |
| Amgen | 1 | $18 |
| ERMI LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$171,769
- TRITANIUM$30,108
- REUNION$29,051
- TRIATHLON$20,256
- ACCOLADE$12,813
- TRIDENT$12,100
- ABG$8,000
- HIPMAP$2,650
- EZOUT$2,250
- 1688$1,500
- PHOTONBLADE$1,000
- CINCHLOCK$600
- CINCHLOCK SS$573
- SALVATION$347
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$313
- OMEGA$233
- ALPHAVENT$233
- Verasense$224
- INSIGNIA$161
- Catalyst Total CSR$155
How this compares
$276,352 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 63 | $1,823 |
| Methylprednisolone | 15 | $172 |
| Ibuprofen | 21 | $138 |
| Oxycodone Hcl | 12 | $117 |
| Meloxicam | 16 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Los Angeles
- Kelly VinceLos Angeles$9.6M
- Jay LiebermanLos Angeles$4.8M
- Thomas SchmalzriedLos Angeles$4M
- David SkaggsLos Angeles$2.6M
- David ThordarsonLos Angeles$2.5M
- Edward McPhersonLos Angeles$1.2M
- Daniel AllisonLos Angeles$1.1M
- Justin SalimanLos Angeles$912K
- Charles MoonLos Angeles$760K
- Andrew SpitzerLos Angeles$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.